Skip to main content

Charming Medical Ltd

corporate_fare Company Profile

Charming Medical Ltd

MCTA·NASDAQ·Healthcare·CIK 0002035992

Charming Medical Limited, through its subsidiaries, provides beauty, wellness, and postpartum services in Hong Kong under the Beauty Lab brand. The company offers services such as womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, traditional Chinese medicine (TCM)-inspired prenatal massage, and Indonesian traditional abdominal binding. Charming Medical also provides TCM-inspired supplement products, including the Beauty Lab home herbal uterine care patch, probiotic intimate wash, and Yin nourishing pill sets. Additionally, it offers beauty products like ginseng soothing anti-allergy moisturizing wash for skin issues and scalp health products. The company provides consultancy services, offering TCM-inspired therapy technical training and dietary therapy training to other beauty salons, massage centers, and similar institutions. Its products are used to alleviate premenstrual syndrome, menstrual irregularities, dysmenorrhea, leukorrhea, pelvic inflammatory disease, menopausal care, breast health, uterine health, enhance physical weakness, balance endocrine functions, and other common women's health issues. Charming Medical operates wellness centers. The company was founded in 2016 and is headquartered in Causeway Bay, Hong Kong.

Charming Medical Ltd (NASDAQ:MCTA) is a publicly traded company in the Healthcare sector. Wiseek monitors MCTA SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Charming Medical Appoints Audit Expert Mei Cai to Board, Tsui Resigns
  • Charming Medical Appoints Audit Committee Financial Expert as Independent Director Amidst Going Concern
  • Charming Medical Discloses SEC Trading Suspension, Nasdaq Halt, and Class Action Lawsuit Following IPO
  • CEO/Chairman Kit Wong Discloses 91.65% Voting Control in Charming Medical Ltd

Insider Transactions

MCTA files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with M →
$29.36
52-week range · as of 2026-05-06 $4.3 – $31.7
Market cap
$438.5M
Volume
4.3M (4.9× avg)
3-mo avg 874.5K
Live data · 2026-06-14 06:08 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MCTA - Latest Insights

MCTA
May 06, 2026, 6:05 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $29.36
Real-time Price: $29.36 info
Change: $0 (0%) info
Market Cap: $438.505M info
MCTA
Apr 02, 2026, 4:20 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $29.36
Real-time Price: $29.36 info
Change: $0 (0%) info
Market Cap: $438.505M info
MCTA
Mar 31, 2026, 12:29 PM EDT
Filing Type: 6-K
Importance Score:
10
Price at Filing: $29.36
Real-time Price: $29.36 info
Change: $0 (0%) info
Market Cap: $438.505M info
MCTA
Mar 27, 2026, 7:19 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $29.36
Real-time Price: $29.36 info
Change: $0 (0%) info
Market Cap: $438.505M info